Cargando…
Drug discovery and design /
Strategies to reduce medical uncertainty and build evidence have become critical to the advancement of medical knowledge and modern medical practice. As new techniques and strategies have arisen, so has the need for a current reference work. Drug Discovery and Design examines the latest research in...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
San Diego, Calif. ; London :
Academic,
�2001.
|
| Colección: | Advances in protein chemistry ;
v. 56. |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn166885237 | ||
| 003 | OCoLC | ||
| 005 | 20231117015046.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 070904s2001 cauaf ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCLCQ |d YDXCP |d OCLCQ |d YUM |d IDEBK |d E7B |d OCLCQ |d MERUC |d OPELS |d OCLCQ |d OPELS |d OCLCQ |d DEBSZ |d UAB |d OCLCQ |d OCLCF |d OCLCO |d D6H |d OCLCO |d CHVBK |d OCLCO |d OCLCA |d OCLCQ |d LEAUB |d OCLCO |d OCLCA |d S2H |d OCLCO |d OCLCQ |d OCLCO |d COM |d OCLCQ |d OCLCO | ||
| 019 | |a 63020266 |a 648270227 |a 742283793 |a 814451413 |a 823106925 |a 823827157 |a 823896624 |a 824088713 |a 824135097 |a 906142861 | ||
| 020 | |a 9780080493381 |q (electronic bk.) | ||
| 020 | |a 0080493386 |q (electronic bk.) | ||
| 020 | |a 0120342561 |q (electronic bk.) | ||
| 020 | |a 9780120342563 |q (electronic bk.) | ||
| 020 | |a 1281010650 | ||
| 020 | |a 9781281010650 | ||
| 035 | |a (OCoLC)166885237 |z (OCoLC)63020266 |z (OCoLC)648270227 |z (OCoLC)742283793 |z (OCoLC)814451413 |z (OCoLC)823106925 |z (OCoLC)823827157 |z (OCoLC)823896624 |z (OCoLC)824088713 |z (OCoLC)824135097 |z (OCoLC)906142861 | ||
| 050 | 4 | |a QD431 |b .A3eb vol. 56 | |
| 072 | 7 | |a MED |x 023000 |2 bisacsh | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 072 | 7 | |a MED |x 072000 |2 bisacsh | |
| 072 | 7 | |a MED |x 058170 |2 bisacsh | |
| 072 | 7 | |a PSD |2 bicssc | |
| 082 | 0 | 4 | |a 615.19 |2 22 |
| 245 | 0 | 0 | |a Drug discovery and design / |c edited by Edward M. Scolnick. |
| 260 | |a San Diego, Calif. ; |a London : |b Academic, |c �2001. | ||
| 300 | |a 1 online resource (xi, 567 pages, 4 unnumbered pages of plates) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Advances in protein chemistry ; |v v. 56 | |
| 505 | 0 | |a "Natural history" clinical trials : an enduring contribution to modern medical practice / Edward M. Scolnick, Eve E. Slater, George W. Williams -- Angiotensin-converting enzyme inhibitors / Joel Menard, Arthur Patchett -- HMG-CoA reductase inhibitors / Roger Illingworth, Jonathan A. Tolbert -- Cyclooxygenase-2 inhibitors / Alan S. Nies -- 5[alpha]-reductase inhibitors / John D. McConnell, Elizabeth Stoner -- Peroxisome proliferator-activated receptor (PPAR)[gamma] agonists for diabetes / David E. Moller, Douglas A. Greene -- Discovery and clinical development of HIV-1 protease inhibitors / Joel Huff, James Kahn -- Calcineurin inhibitors and the generalization of the presenting protein strategy / Kurt W. Vogel [and others] -- Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities / Fernand Labire [and others] -- Monoclonal antibody therapy / John W. Park, Josef Smolen -- Glucan synthase inhibitors as intifungal agents / Myra B. Kurtz, John H. Rex. | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 520 | |a Strategies to reduce medical uncertainty and build evidence have become critical to the advancement of medical knowledge and modern medical practice. As new techniques and strategies have arisen, so has the need for a current reference work. Drug Discovery and Design examines the latest research in the development of these new strategies. Some of the topics covered include angiotensin converting enzyme inhibitors, HIV protease inhibitors, PPAR agonists for diabetes, and glucan synthase antifungal agents. | ||
| 650 | 0 | |a Drugs |x Design. | |
| 650 | 0 | |a Drug development |x Methodology. | |
| 650 | 2 | |a Drug Design |0 (DNLM)D015195 | |
| 650 | 2 | |a Drug Evaluation |0 (DNLM)D004341 | |
| 650 | 6 | |a M�edicaments |x Conception. |0 (CaQQLa)201-0203461 | |
| 650 | 6 | |a M�edicaments |0 (CaQQLa)201-0306620 |x D�eveloppement |0 (CaQQLa)201-0306620 |x M�ethodologie. |0 (CaQQLa)201-0379663 | |
| 650 | 7 | |a MEDICAL |x Drug Guides. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacy. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Nursing |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Drugs |x Design |2 fast |0 (OCoLC)fst00898790 | |
| 650 | 1 | 7 | |a Eiwitten. |2 gtt |
| 650 | 1 | 7 | |a Geneesmiddelen. |2 gtt |
| 650 | 1 | 7 | |a Enzymen. |2 gtt |
| 700 | 1 | |a Scolnick, Edward M. | |
| 776 | 0 | 8 | |i Print version: |t Drug discovery and design. |d San Diego, Calif. ; London : Academic, �2001 |z 0120342561 |z 9780120342563 |w (OCoLC)46393289 |
| 830 | 0 | |a Advances in protein chemistry ; |v v. 56. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780120342563 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00653233/56 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00653233 |z Texto completo |